Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer. uri icon

Overview

publication date

  • December 1, 2010

Research

keywords

  • Carcinoma, Non-Small-Cell Lung
  • Gene Rearrangement
  • Lung Neoplasms
  • Protein-Tyrosine Kinases
  • Pyrazoles
  • Pyridines

Identity

Scopus Document Identifier

  • 78650436429

Digital Object Identifier (DOI)

  • 10.1097/JTO.0b013e318200f9ff

PubMed ID

  • 21102269

Additional Document Info

volume

  • 5

issue

  • 12